Literature DB >> 17878127

Chemotherapy-related change in cognitive function: a conceptual model.

Lisa M Hess1, Kathleen C Insel.   

Abstract

PURPOSE/
OBJECTIVES: To develop a conceptual model of chemotherapy-related changes in cognitive function. DATA SOURCES: MEDLINE, CINAHL, HealthStar, and PsycINFO databases. DATA SYNTHESIS: Patients undergoing chemotherapy often complain of forgetfulness, absentmindedness, and an inability to focus when performing a variety of daily tasks. Changes in cognitive function have been referred to by the colloquial term "chemo-brain." The authors conducted an examination of the literature to investigate relationships among concepts and to synthesize current knowledge.
CONCLUSIONS: Cognitive function, defined as higher-order mental processes, may be altered along two distinct and interacting pathways: (a) the cancer diagnosis, which can lead to anxiety, stress, distress, and depression; and (b) the direct physiologic effects of cancer treatment. The Chemotherapy-Related Change in Cognitive Function conceptual model is informed by a review of literature that illustrates antecedents, moderators, mediators, and consequences that may be relevant to this issue. IMPLICATIONS FOR NURSING: When a patient presents with cognitive complaints, the problems can be evaluated for intervention when an overall understanding exists of chemotherapy-related cognitive changes based on a conceptual model that continues to be informed through well-conceptualized and well-designed research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878127     DOI: 10.1188/07.ONF.981-994

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  35 in total

1.  Evaluation of multiple neurotoxic outcomes in cancer chemotherapy.

Authors:  Bernard Weiss
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 2.  What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.

Authors:  Annalynn M Williams; Clive S Zent; Michelle C Janelsins
Journal:  Br J Haematol       Date:  2016-07-08       Impact factor: 6.998

3.  Potential factors associated with perceived cognitive impairment in breast cancer survivors.

Authors:  Jamie S Myers; Jo A Wick; Jennifer Klemp
Journal:  Support Care Cancer       Date:  2015-04-03       Impact factor: 3.603

4.  Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy.

Authors:  John D Merriman; Catherine Jansen; Theresa Koetters; Claudia West; Marylin Dodd; Kathryn Lee; Steven M Paul; Bradley E Aouizerat; Bruce A Cooper; Patrick S Swift; William Wara; Christine Miaskowski
Journal:  Oncol Nurs Forum       Date:  2010-07       Impact factor: 2.172

5.  The experience of cognitive change in women with breast cancer following chemotherapy.

Authors:  Mary Louise Kanaskie; Susan J Loeb
Journal:  J Cancer Surviv       Date:  2014-10-25       Impact factor: 4.442

6.  Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.

Authors:  I Glimelius; S Ekberg; J Linderoth; M Jerkeman; E T Chang; M Neovius; K E Smedby
Journal:  J Cancer Surviv       Date:  2015-02-18       Impact factor: 4.442

7.  Relationship between self-reported cognitive function and work-related outcomes in breast cancer survivors.

Authors:  Diane Von Ah; Susan Storey; Adele Crouch
Journal:  J Cancer Surviv       Date:  2017-12-08       Impact factor: 4.442

Review 8.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

9.  Preliminary evidence of an association between an interleukin 6 promoter polymorphism and self-reported attentional function in oncology patients and their family caregivers.

Authors:  John D Merriman; Bradley E Aouizerat; Dale J Langford; Bruce A Cooper; Christina R Baggott; Janine K Cataldo; Anand Dhruva; Laura Dunn; Claudia West; Steven M Paul; Christine S Ritchie; Patrick S Swift; Christine Miaskowski
Journal:  Biol Res Nurs       Date:  2013-03-11       Impact factor: 2.522

10.  Advanced cognitive training for breast cancer survivors: a randomized controlled trial.

Authors:  Diane Von Ah; Janet S Carpenter; Andrew Saykin; Patrick Monahan; Jingwei Wu; Menggang Yu; George Rebok; Karlene Ball; Bryan Schneider; Michael Weaver; Eileen Tallman; Fred Unverzagt
Journal:  Breast Cancer Res Treat       Date:  2012-08-24       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.